Rui Avelar
Förmögenhet: 3 M $ per 2026-09-30
Förmögenhet: 3 M $ per 2026-09-30
Rui Avelar is currently Chief Medical Officer, Head-Research & Development at Evolus, Inc. since 2018.
Formerly, Dr. Avelar was Chief Medical Officer at AEON Biopharma Sub, Inc. from 2014 to 2018 and Chief Medical Officer at Allergan Medical Optics from 2011 to 2013.
Dr. Avelar earned a doctorate from the University of Toronto in 1989.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
EVOLUS, INC. 0,6 % | 2026-04-17 | 388 999 ( 0,6 % ) | 3 M $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| EVOLUS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2014-01-01 |
| Företag | Position | Slut |
|---|---|---|
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Teknisk/Vetenskaplig/F&U Direktör | 2018-02-01 |
Allergan Medical Optics | Teknisk/Vetenskaplig/F&U Direktör | 2013-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Evolus, Inc.
Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Medical Optics | Electronic Technology |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån